Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Evaxion to announce business update and third quarter 2024 financial results on October 31
-
ViaNautis Bio Signs Strategic Collaboration Agreement with Lilly to leverage its polyNaut® platform to develop novel products delivering genetic medicines
-
Condor’s Workover Results Continue to Exceed Pre-Job Expectations
-
BrainHQ Awarded New Army Contract
-
Vantage Drilling International Ltd. Schedules Third Quarter 2024 Earnings Release Date and Conference Call
-
NACEPF and Mobile Beacon Support Calls for Reconsideration of Certain E-Rate Program Limitations
-
AI Strategy Expert Brian Knudson Joins FTI Consulting
-
Yorbeau is planning a major exploration program of more than $2.0 million on its properties in the Selbaie and Val D’Or areas of Quebec in 2024 and 2025
-
VR Announces $450K Non-Brokered Private Placement to Commence Exploration on Empire and Silverback Gold - Copper Projects in Ontario
-
Purpose Investments Inc. Announces Final October 2024 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
Territorial Bancorp Inc. Announces Third Quarter 2024 Results
-
SL Green Inks 72,500 Square-Foot Lease With Verition Group at 245 Park Avenue
-
Reflexivity Raises $30 Million in Series B Funding
-
Form 8.3 - Equals Group PLC
-
Fly PLAY hf.: Manager´s transactions
-
The World's First IPO of Universal Autonomous Driving Technology Company! WeRide Officially Listed on Nasdaq
-
The World's First IPO of Universal Autonomous Driving Technology Company! WeRide Officially Listed on Nasdaq
-
International Petroleum Corporation Announces Results of Normal Course Issuer Bid
-
Mastering Document Verification with Reference Data: Key Insights from Regula's Talk at INTERDOCPOL Congress
-
Mastering Document Verification with Reference Data: Key Insights from Regula's Talk at INTERDOCPOL Congress
-
Fuse Supports Combat Search and Rescue Exercise for Navy
-
Net Asset Value(s)
-
Legible Releases FrankensteinAI with Spellbinding AI Chat Feature Just in Time for Halloween
-
Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024
-
Gilat Received Over $4 Million Order from the US Department of Defense
-
Solar Alliance signs contract for $3.7 million solar project in Kentucky
-
Fractyl Health to Present Compelling Weight Maintenance Data from both Revita® and Rejuva® Platforms at ObesityWeek® 2024
-
Aecon enhances North American nuclear capability with agreement to acquire United Engineers & Constructors Inc.
-
NexGold Intersects Visible Gold 70 metres below a previous result of 193 g/t over 1 metre showing extension to the C Zone East area at the Goliath Deposit
-
Monte Rosa Therapeutics Announces Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders
-
Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
-
EyePoint Pharmaceuticals Announces Positive Interim 16-Week Data for Ongoing Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema
-
Aura Minerals to Acquire Bluestone Resources
-
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
-
Humacyte Announces Presentation of Positive Results from V007 Phase 3 AV Access Clinical Trial at the American Society of Nephrology’s Kidney Week 2024
-
Pipe Launches Embedded Business Card for Software and Payment Companies, Expanding Their Suite of Embedded Financial Solutions
-
Local News Live Announces Election Night Coverage
-
Lithium Ionic Joins United Nations Global Compact Initiative
-
Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024
-
Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority
-
Evoke Pharma & EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users with Diabetic Gastroparesis using GIMOTI®
-
Amwell to participate in upcoming investor conferences
-
Anchor Peabody Signals Growth, Expansion with Slate of New Hires
-
PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
-
Bitfarms Appoints Rachel Silverstein as U.S. General Counsel
-
Local News Live Announces Election Night Coverage
-
Telesat and Airbus begin collaboration to integrate Telesat Lightspeed services into HBCplus portfolio
-
Velcan Holdings: Share buyback program - weekly statement
-
Purespring Therapeutics presents new preclinical data on novel gene therapy for IgA Nephropathy at ASN Kidney Week 2024
-
Šiaulių Bankas invitation to Q3 2024 Financial Results webinar

